The Impact of Hepatic Steatosis on the Outcome of Pegylated Interferon and Ribavirin Therapy in Patients with Chronic Hepatitis C Genotype 4
Hassan Mohamed Abd El Rahman Abd El Aty;
Abstract
Hepatic steatosis is frequent histological finding in patients with chronic HCV and it is one of the characteristic features of chronic hepatitis C. Steatosis affects chronic hepatitis C progression. Hepatic fibrosis is the most important factor for estim
Other data
| Title | The Impact of Hepatic Steatosis on the Outcome of Pegylated Interferon and Ribavirin Therapy in Patients with Chronic Hepatitis C Genotype 4 | Other Titles | مردود التدهن الكبدي علي نتائج العلاج الدوائي بالأنترفيرون الطويل المفعول مع الريبافيرين في المرضي المصابين بالالتهاب الكبدي الفيروسي (سي) المزمن النمط الجيني (٤) | Authors | Hassan Mohamed Abd El Rahman Abd El Aty | Keywords | The Impact of Hepatic Steatosis on the Outcome of Pegylated Interferon and Ribavirin Therapy in Patients with Chronic Hepatitis C Genotype 4 | Issue Date | 2011 | Description | Hepatic steatosis is frequent histological finding in patients with chronic HCV and it is one of the characteristic features of chronic hepatitis C. Steatosis affects chronic hepatitis C progression. Hepatic fibrosis is the most important factor for estim |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.